Results 131 to 140 of about 2,365,736 (349)

The Politics of Public Health: A Response to Epstein [PDF]

open access: yes, 2003
Conservatives are taking aim at the field of public health, targeting its efforts to understand and control environmental and social causes of disease. Richard Epstein and others contend that these efforts in fact undermine people’s health and well-being
Bloche, Maxwell Gregg   +1 more
core   +1 more source

Annual 12‐Week Dosing Gap of Natalizumab: Clinical Efficacy, Blood Biomarkers, and CSF Cell Composition

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Natalizumab (NTZ) is a highly effective therapy for multiple sclerosis (MS); however, its use is limited by the risk of a rare potentially severe opportunistic brain infection, progressive multifocal leukoencephalopathy (PML). Alternative dosing strategies are evaluated to reduce PML risk while still maintaining efficacy, which ...
Regina Berkovich   +10 more
wiley   +1 more source

Interleukin‐6 as a Key Biomarker in Facioscapulohumeral Dystrophy: Evidence From Longitudinal Analyses

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini   +13 more
wiley   +1 more source

Relapsing–Remitting Multiple Sclerosis Is Associated With a Dysbiotic Oral Microbiome

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Multiple sclerosis (MS) is a chronic autoimmune disorder characterized by inflammation, demyelination, and neurological impairment. While the gut microbiota's role in MS is extensively studied, the association between the oral microbiota and MS remains underexplored, particularly in North American cohorts.
Sukirth M. Ganesan   +12 more
wiley   +1 more source

Delayed Giant Splenic Artery Aneurysm Following Splenic Infarction in a Patient with Infective Endocarditis

open access: yesInternational Medical Case Reports Journal
Zhaxi Yangzong,1,* Xiying Gui,1,* Qingping Wen,1,* Hua Qian,1 Li Shi,1 Xinchao Liu1,2 1Department of Infectious Disease, Tibet Autonomous Region People’s Hospital, Lhasa, People’s Republic of China; 2Department of Infectious ...
Yangzong Z   +5 more
doaj  

Diseases and Development [PDF]

open access: yes
This paper examines two related questions: what effects do infectious diseases exert on growth and development, and are they quantitatively important?
Chris Papageorgiou   +2 more
core  

Controlling for Severity of Illness in Outcome Studies Involving Infectious Diseases: Impact of Measurement at Different Time Points

open access: green, 2008
Kerri A. Thom   +7 more
openalex   +1 more source

Infectious Diseases

open access: yesJournal of the Royal College of Physicians of London, 1991
R S, Heyderman, E, Larson
openaire   +2 more sources

Scoliosis Surgery in a Patient With Advanced Friedreich's Ataxia—It Is Not Too Late

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Friedreich's ataxia is a multisystem disorder with scoliosis being the most common non‐neurological manifestation. While scoliosis surgery is typically performed in adolescent, ambulatory patients, few data exist on surgical outcomes in patients with advanced disease.
Kathrin Reetz   +20 more
wiley   +1 more source

Rabies encephalitis following Post Exposure prophylaxis (PEP) is becoming an evolving problem in Bangladesh

open access: yesThe Microbe
Rabies is one of the oldest and deadliest disease in the world and causes a significant number of deaths. Over 95 % of all human deaths from rabies occur in Asia and Africa. Bangladesh is endemic to rabies.
Shrebash Paul   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy